z-logo
Premium
Cowden syndrome and lhermitte‐duclos disease
Author(s) -
Albrecht S.,
Haber R. M.,
Goodman J. C.,
Duvic M.
Publication year - 1992
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19920815)70:4<869::aid-cncr2820700424>3.0.co;2-e
Subject(s) - cowden syndrome , medicine , hamartoma , papillomatosis , pathology , thyroid , dermatology , pten , apoptosis , biochemistry , chemistry , pi3k/akt/mtor pathway
Background . Cowden syndrome (CS) is a rare but underdiagnosed autosomal dominant condition also known as “multiple hamartoma‐neoplasia syndrome.” Patients have multiple tricholemmomas (a type of benign skin appendage tumor) and oral papillomatosis and cutaneous keratoses. They often have goiter, gastrointestinal polyps, and hamartomatous soft tissue lesions. Breast cancer affects approximately one third of women with CS. Lhermitte‐Duclos disease (LDD) is a peculiar proliferation of abnormal neuronal elements of the cerebellum that has features of a hamartoma and of a neoplasm. Methods . The authors described two patients who have both CS and LDD. Also reviewed were 50 of approximately 62 previously described cases of LDD (identified through literature searches) in an effort to find patients with LDD who had other associated lesions. Results . Only one other patient in whom both LDD and CS were recognized has been reported. In addition, a number of patients with LDD who had other neoplasms and/or thyroid lesions have been described. Conclusions . Given the rarity of these two entities, we believe that their association is not fortuitous. LDD fits into the concept of CS as a hamartoma‐neoplasia syndrome. In addition, a number of patients with LDD who had other neoplasms or thyroid lesions have been reported, raising the possibility that CS and LDD are more closely linked than is generally appreciated. We suspect that there are more patients with LDD who have unrecognized CS. Patients with either of the two diseases should be examined and followed up for evidence of the other. Cancer 1992; 70:869–876.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here